NewsResearchTreatment Two research studies funded by HLP were presented at 2023 ASCO annual meeting Last week was the 2023 American Society of Clinical Oncology (ASCO) conference in Chicago. The…rdsupportJune 19, 2023
NewsResearchTreatment Ellipses Pharma presents ‘encouraging’ data on selective RET inhibitor EP0031, ASCO 2023 annual conference Data of the Phase 1 Study of KL590586 (EP0031/A400), presented at ASCO, reported preliminary efficacy…rdsupportJune 19, 2023
EducationNewsResearchResourcesTreatment DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies: June 27 – July 1 The DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies is a five-day meeting comprising seven…rdsupportJune 19, 2023
NewsResearchVideos Virtual Event: 2022 RET Cancer Research Update (Watch Video) The Happy Lungs Project hosted a 2022 Research Update, featuring presentations about advances for RET-positive…rdsupportDecember 13, 2022
NewsResearchResources Participants Needed: Epidemiology of Young Lung Cancer Study Epidemiology of Young Lung Cancer is a clinical study for patients who were diagnosed with…rdsupportNovember 29, 2022
NewsResearch Dr. Irene Guijarro Munoz Named Our Science Liaison & Research Manager Dr. Irene Guijarro Munoz has been named the Science Liaison and Research Manager for the…rdsupportSeptember 27, 2022
Fund RaisingNewsPress ReleasesResearch Press Release: Partnering on Innovative Lung Cancer Research The Happy Lungs Project is pleased to share research that we are funding in collaboration…rdsupportMay 31, 2022
Fund RaisingNewsResearch Donors Pledge $2 Million Dollars to Happy Lungs Project in Matching Grant to Fight Lung Cancer The Happy Lungs Project, Inc., a 501c3 non-profit, was awarded a $2 million matching grant…rdsupportMay 30, 2022
NewsPress ReleasesResearch Press Release: Four Major US Cancer Centers Advance RET+ Lung Cancer Research New Research Collaboration Set To Attack RET Driven Non-Small Cell Lung Cancer April 6, 2022…rdsupportApril 6, 2022
NewsResearch New Collaborative Research To Target RET-Driven NSCLC New Research Collaboration Set To Attack RET Driven Non-Small Cell Lung Cancer Through the support…rdsupportDecember 30, 2021